Nostrum Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM PHARMS LLC, and what generic and branded alternatives to NOSTRUM PHARMS LLC drugs are available?
NOSTRUM PHARMS LLC has three approved drugs.
Drugs and US Patents for Nostrum Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nostrum Pharms Llc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 076756-001 | Jul 26, 2006 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Nostrum Pharms Llc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 076756-002 | Dec 12, 2011 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Nostrum Pharms Llc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 200430-001 | Apr 4, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-004 | Feb 21, 1985 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-005 | Aug 9, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Nostrum Pharms Llc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 200430-003 | Apr 4, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-003 | Feb 21, 1985 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.